Panos G Kanavos (Panos Kanavos)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Health Promotion

Top Venues

International journal of general medicine

Applied health economics and health policy

The European journal of health economics : HEPAC : health economics in prevention and care

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Giovanny Leon, Christophe Carbonel, Aparajit Rampuria, Ravindra Singh Rajpoot, Parth Joshi, Panos G Kanavos
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries. The European journal of health economics : HEPAC : health economics in prevention and care (2024)
Daniel Tobias Michaeli, Mackenzie Mills, Panos G Kanavos
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland. Applied health economics and health policy 20 (5) (2022)
Daniel Tobias Michaeli, Mackenzie Mills, Thomas Michaeli, Aurelio Miracolo, Panos G Kanavos
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investigational new drugs 40 (4) (2022)
Panos G Kanavos, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Value Insider Season 1 Episode 6: How Will Market Access and Value Demonstration Evolve? (Future Outlook) [Podcast]. International journal of general medicine 15 (2022)
Panos G Kanavos, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Value Insider Season 1 Episode 6: How Will Market Access and Value Demonstration Evolve? (Future Outlook) [Podcast]. International journal of general medicine 15 (2022)